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ABSTRACT
Background The United Kingdom (UK) lags behind other high-income countries 
in relation to technological innovation in healthcare. We sought to understand what 
national strategies can help to promote a climate for innovation in healthcare set-
tings by extracting lessons for the UK from international innovators.
Methods We undertook a series of qualitative semi-structured interviews with 
senior international innovators from a range of health related policy, care/service 
delivery, commercial and academic backgrounds. Thematic analysis helped to 
explore how different factors could facilitate/inhibit innovation at individual, organ-
isational and wider societal levels.
Results We conducted 14 interviews and found that a conducive climate for 
healthcare innovation consisted of national/regional strategies stimulating commer-
cial competition, promoting public/private relationships, and providing central direc-
tion (e.g. incentives for adoption and regulation through standards) without being 
restrictive. Organisational attitudes with a willingness to experiment and to take 
risks were also seen as important, but a bottom-up approach to innovation, based 
on the identification of clinical need, was seen as a crucial first step to construct 
relevant national policies. 
Conclusions There is now a need to create mechanisms through which front-
line National Health Service staff can raise ideas/concerns and suggest opportuni-
ties for improvement, and then build national innovation environments that seek to 
address these needs. This should be accompanied by creating competitive health 
technology markets to stimulate a commercial environment that attracts high-quality 
health information technology experts and innovators working in partnership with 
staff and patients.
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BACKGROUND
Global societal challenges surrounding population growth and 
the associated threats to health and the sustainability of health 
care systems have put technological innovation high on many 
national policy agendas, resulting in international efforts to 
excel in this area.1 Examples of countries that do particularly 
well in this respect include the United States (US), which is 
regarded as an international leader in healthcare innovation; 
Taiwan has made a global name in production innovation; and 
Germany is seen as a leader in developing professional inno-
vation capacity (see Box 1).2–10 The United Kingdom (UK) is, 
however, lagging behind – of particular concern is that despite 
a number of initiatives to stimulate activity, overall innovation-
related activity is declining.11,12
There is also a lot to be learnt from other industries, where 
significant work is taking place in order to stay ahead of the 
competition.13 The retail sector, for example, has seen an 
enormous growth in personalising advertising and shopping 
experiences,14 and financial services have been transformed 
by online access and virtual forms of money.15 However, 
UK healthcare is struggling in relation to both technological 
innovation (many currently used tools are relatively anti-
quated when compared to the commercial sector) and 
related service transformation (new technologies are often 
seen as an unwelcome disruption to existing ways of work-
ing). Underlying reasons include the high level of regulation 
in the National Health Service (NHS), its centralised nature, 
sensitivity of health-related data, the variety of highly special-
ised and autonomous healthcare workers from different pro-
fessions using new technologies and the generally high-risk 
environment of care provision.16–18 The imperative to pro-
mote innovation demands that these challenges are negoti-
ated and, if necessary, overcome.19
There are potentially important lessons to be learnt from 
international settings, particularly those that have created local 
and national environments that enable innovation in health-
care to flourish. Existing empirical work has mainly focused 
on exploring innovation climates in organisational settings and 
specific teams,20–22 and we therefore aimed to identify what 
national strategies can help to promote a climate for innovation 
in healthcare settings through seeking potentially transferable 
lessons for the UK from international innovators. 
METHODS
We conducted a qualitative study using semi-structured inter-
views with a range of innovators from international healthcare 
settings.
Ethical approval
This work received ethical approval from the Centre for 
Population Health Sciences at The University of Edinburgh, 
UK. All participants were fully aware of what participation 
entailed, were given the opportunity to ask questions before-
hand, and gave written consent to participate. To ensure con-
fidentiality of personal data, all participants were identified 
using a number. All interview transcripts were anonymised 
and any potentially disclosing information relating to places 
or people was removed. 
Recruitment of participants
We scoped the existing literature surrounding health infor-
mation technology (HIT) and innovation, to develop a pur-
posive sampling frame for recruiting participants.23 This 
involved collating examples of innovations under the fol-
lowing broad headings: technological, social, organisa-
tional and national strategies (see Tables 1 and 2). For 
each of the example technologies identified, we searched 
the internet to find key senior contacts (e.g. head of com-
pany or senior academic). One contact was approached per 
exemplar technology, resulting in 38 invitations being sent. 
In doing so, we paid attention to sampling a range of par-
ticipants from different backgrounds including technology, 
engineering, academia, policy, and clinical settings. We 
also approached participants from a range of international 
settings, although most respondents were from the US. 
Participants were approached via email to enquire if they 
were interested in participating, with a follow-up email sent 
two weeks later. Out of the 38 participants we approached, 
19 responded and interviews were arranged with 14. The 
remainder either cancelled due to other commitments or did 
not reply to follow-up emails.
Data collection and handling
We conducted 14 telephone/Skype interviews with stakehold-
ers. Interviews were structured around existing needs/expe-
riences and features of the relevant stakeholder/technology, 
and around exploring which factors were perceived to facili-
tate/inhibit an innovation climate in healthcare (see Box 2 for 
the topic guide). Discussions were digitally audio-recorded 
and transcribed verbatim by a professional transcriber. The 
number of interviews was determined through the principle of 
thematic saturation – we stopped collecting new data when no 
major new themes were emerging in the concurrent analysis.24 
Findings were fed back to individual participants through send-
ing a summary of the results, which resulted in minor modifica-
tions mainly in relation to adding clarification (e.g. surrounding 
US-centric concepts such as value-based care). 
Data analysis
Qualitative data collection and analysis was iterative, allow-
ing emerging themes to be examined further and disconfirm-
ing evidence to be sought.25 Multiple perspectives allowed 
exploring views surrounding innovation from different angles 
and identifying where and how different data converged and 
diverged.26
The transcripts were checked for accuracy by KC and 
uploaded onto NVivo10, a qualitative analysis software pack-
age.27 Initial coding of data involved using the topic guide as 
a coding framework (the deductive component of the analy-
sis), whilst also allowing emerging themes to develop (the 
inductive component).25 All authors discussed the coding 
framework and coding was conducted by KC.
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Box 1 International examples of innovation strategies
The Silicon Valley model – innovation ideas hub1,2
Biggest high-tech manufacturing centre in the US
High concentration of commercial companies located in the area
Stanford University links
High venture capital investment
Focus on generating innovation ideas
Companies start small but with the constant aim to scale up
Recruit the most talented people through innovative interviews (e.g. idea jamming sessions)
Model of co-creation of products with customers
Employees are actively engaged in business and innovative ideas help to strive (boomerang passes, testing ideas, thinking 
outside the box)
Cross-fertilisation with other industries and international experts
The Taiwanese model – focus on production innovation3–6
Using globalisation to their advantage
Focus on manufacturing activity
Increasing patenting activity
Increasing focus on contract manufacturing
Many small and medium enterprises integrated with global production networks 
Close collaboration between firms
Bringing together experts from different areas to work together
Flexible production system (focus on making small parts that can be used for a variety of products)
Global collaboration (production of products design elsewhere)
Strong governmental support for innovation
German approach – increasing innovation capacity7–9
Focus on driving innovations that ensure that productivity gains are broad rather than concentrated on small sectors or parts 
of the population (focus is not on new products but on enhancing existing ones)
Established position of governmentally subsidised institutions that help companies move from idea to market on a large scale
Constant high-quality training of the workforce (both practical and theoretical, resulting in highly specialised workers)
Empowering workers
Valuing engineers
Improving productivity
Large number of technology manufacturing firms
Ranking high on research and development (R&D) intensity, manufacturing capability, high-tech density, and patent activity
1.  http://www.forbes.com/sites/kevinready/2015/11/10/japans-emerging-culture-of-innovation-the-invisible-things-can-be-the-hardest-to-
change/
2. http://www.fastcodesign.com/3026220/tap-into-the-7-secrets-of-silicon-valleys-innovation-culture
3. https://hbr.org/2014/11/why-silicon-valley-shouldnt-be-the-model-for-innovation
4. http://www.cosmeticsdesign-asia.com/Market-Trends/Taiwan-and-South-Korea-named-as-Asia-s-innovation-leaders
5. http://images.businessweek.com/bloomberg/pdfs/most_innovative_countries_2014_011714.pdf
6.  Lee, P. C., & Su, H. N. (2015, August). Evolution of science, technology and innovation policy in Asia: Case of China, 
South Korea, Japan and Taiwan. In Management of Engineering and Technology (PICMET), 2015 Portland International 
Conference on (pp. 184-191). IEEE.
7. https://hbr.org/2014/05/why-germany-dominates-the-u-s-in-innovation/
8. http://images.businessweek.com/bloomberg/pdfs/most_innovative_countries_2014_011714.pdf
9.  Bartelsman, E., Dobbelaere, S., & Peters, B. (2014). Allocation of human capital and innovation at the frontier: Firm-level 
evidence on Germany and the Netherlands. Industrial and Corporate Change, dtu038.
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Table 1 Indicative sampling frame of technological 
innovation in healthcare and potential exemplar areas
Innovation Exemplar area
Technological Robotics 
Artificial intelligence
3D printing
Cloud technology
Holographic images
Social Patient facing digital technologies
Citizen-driven health
Diagnostics and procedures
Innovation in work practices and interdisciplinary 
working
Organisational Workforce development
Process innovation: innovation in service 
delivery
Process innovation: innovation in business 
process management
National strategy Integration of health and social care
Learning health systems
Public health: interdisciplinary skills, data 
analytics
Partnerships: healthcare, research, commercial
Big data: analytics, research, linked data, 
methods, tools and standards
Box 2 Sample topic guide
Views on innovation in healthcare (think both product and 
process innovation)
 • What are currently the most promising developments in 
HIT innovation?
 • What are the benefits associated with these?
Vision surrounding technological innovation in healthcare
 • Fast forward 10 years – how should healthcare look like? 
 • What will help us achieve this? 
Experiences of technological innovation in healthcare
 • How are healthcare organisations deciding on which 
innovations to pursue?
 • How does healthcare differ from other sectors?
 • Which factors hinder developments and how might 
these be addressed?
Accelerating innovation in healthcare
 • What can different stakeholders do to promote 
innovation in healthcare?
 • How can policies help to accelerate HIT innovation?
 • What can organisations do accelerate HIT innovation?
Anything else?
RESULTS
Interviewees identified a range of aspects that were per-
ceived to characterise a climate for innovation in healthcare 
settings (see Box 3). These ranged from health system fac-
tors, over organisational factors in healthcare and commer-
cial organisations, to individual-level factors. 
Box 3 Overview of themes
National strategies and regulatory environments
Free markets stimulating innovation
Incentives to facilitate short-, medium-, and longer-term 
innovative activity
National guidance and regulation without stifling innovation
Cross-sectorial collaboration and organisational 
attitudes
Public/private collaboration
Organisational attitudes: risk-taking and willingness to 
experiment
Ensuring that innovation in healthcare is needs-based
Development of technology should be needs-driven
Work practices of healthcare professionals, human interac-
tion and patient needs
Maturity of solutions and associated policies 
National strategies and regulatory 
environments
Governmental approaches to stimulate innovation: 
free markets
US-based interviewees argued that it was the nature of the 
free market in healthcare and the resulting competition that 
stimulated innovation in healthcare settings in their country. 
Competition between healthcare providers, it was argued, 
meant that patients ‘shopped around’, and in order to stay 
competitive, significant investments in innovation had to 
be made, which contributed to industry innovators being 
attracted to the healthcare sector. 
I think what creates a climate is the fact that so much 
of healthcare is really controlled by sort of the market 
place…I think the fact that there’s so much investment in 
healthcare that it’s really developing within the free market 
economy is sort of leading innovators and entrepreneurs 
into that space. (Participant 13, Academic/Clinician)
Conversely, the publicly funded nature of the NHS, the rela-
tively low per capita spending on healthcare and the relatively 
small size meant that innovative activities were restricted by 
a lack of funding and limited organisational motivation to 
operate as commercial enterprises. This, in turn, deterred 
innovators from being attracted to the sector. 
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Table 2 Participant characteristics
Participant number Area Background Country Gender
Participant 1 Smart technology Technologist USA M
Participant 2 Anonymisation 
technology
Technologist Netherlands M
Participant 3 Human factors Academic USA F
Participant 4 Epidemiology Clinical informatics USA M
Participant 5 Policy Health IT strategy USA M
Participant 6 Data analytics Academic USA F
Participant 7 Patient-generated data Technologist/Engineer Spain M
Participant 8 Natural language 
processing
Technologist/Engineer UK M
Participant 9 Open source Policy/Technologist USA F
Participant 10 Virtual reality Engineering USA M
Participant 11 Innovation center Clinical USA M
Participant 12 Population health 
management
Analytics USA F
Participant 13 Primary care Academic/Clinician USA M
Participant 14 Smart cities Business Innovation USA M
I think what makes corporate America world class is 
their logistics because everything is a negotiation here. 
Now some of that will not fit in a cultural way with what 
is happening in [UK] but there’s certainly opportunities 
to have those conversations where we may come up 
with some ideas that might be suitable... (Participant 14, 
Business Innovation)
Governmental approaches to stimulate innovation: 
incentives to facilitate short-, medium-, and longer-
term innovative activity
Incentives were seen as an important way to stimulate com-
petition amongst healthcare providers. For example, the 
stimulus package associated with the US Health Information 
Technology for Economic and Clinical Health Act28 was seen 
to have attracted innovators and as helping to focus organ-
isational efforts on technological innovation. 
I’m amazed the 40 billion dollars triggered a trillion more 
software investment from the healthcare system in the 
US and so it really, the stimulus worked much better than 
even I predicted. (Participant 11, Clinician)
However, interviewees cautioned that although the financial 
incentives stimulated investments in technological inno-
vation, there was also a risk that new technologies were 
adopted in order to obtain payments as opposed to improve 
care. Longer-term innovative activity was therefore not 
viewed to be positively affected by financial incentives, as 
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these only had a short-term effects relating to initial invest-
ment in acquiring new technology. In contrast, participants 
suggested that the recent shift in the US towards value/out-
come-based care (as opposed to service-based care) was 
an important step towards facilitating a longer-term innova-
tion climate.
…most of [providers] do it the big bang theory…they get 
the incentive for the first year and then the second year 
they don’t and it’s like ‘OK let’s find another programme 
then’. So what has happened is programme chasing. 
(Participant 12, Analytics)
National guidance and regulation without stifling 
innovation
Political strategy and guidance was viewed as important to 
ensure interoperability and coordinated efforts, but inter-
viewees highlighted that although crucial, nationally set 
certification standards (such as those in the US Meaningful 
Use Criteria) should not be too restrictive as this could stifle 
innovation. One suggested way to achieve this balance was 
setting general objectives nationally (e.g. implementing elec-
tronic health record technology), whilst still allowing flexibility 
and creative space to innovate (e.g. through choice of tech-
nology and interfaces).
To support innovation sometimes it’s better to sort of 
just lay out the rules of the road but let [providers] fig-
ure out what they need to take from that. (Participant 6, 
Academic)
Similarly, the regulatory environment in the healthcare sec-
tor was seen by most innovators as inhibiting innovative 
activity. Privacy and security directives were often men-
tioned in the context of digital data, as they were seen to 
hinder sharing and collaboration between sectors (as data 
could not move freely). This was seen to be particularly true 
for Europe, where such regulations (e.g. the Data Protection 
Act) prohibited speedy experimental development of new 
technologies.
One of the things why in the States they are more 
advanced than here in Europe is about privacy…here we 
are very, blocking those innovations…in the States first 
they test and then they do all the privacy. It doesn’t mean 
that they don’t have privacy, it means that they have it 
a step later when they test the technology, so this really 
helps to speed up things. (Participant 7, Technologist/
Engineer)
Licencing laws were mentioned in the context of devices, 
where lengthy evaluation periods often meant that function-
alities were lacking flexibility and jeopardised market rel-
evance. Participants therefore called for more flexibility and 
regulations tailored to functionalities of different devices. 
Yeah so healthcare actually is very slow I think because 
of the regulatory environment primarily. The intense 
focus on everything being over-analysed by a regulatory 
body. (Participant 1, Technologist)
Cross-sectorial collaboration and provider 
attitudes 
Public/private collaboration
Participants discussed many factors that influenced 
organisational innovation climates, comparing between 
healthcare and other industries, and also between US and 
UK settings. Overall, collaboration between public and pri-
vate entities (including providers, policy, industry, patients, 
academia and insurers) was argued to be key to successful 
approaches to innovation. 
…the more we make [innovation] siloed, the less there is 
innovation. (Participant 12, Analytics)
This collaborative model should comprise concerted efforts 
to streamline investments across providers and developing 
incubator communities involving different stakeholder groups 
with the common motivation to innovate. Experiences from 
successful health system initiatives and other industries were 
used to illustrate how this had been achieved through discus-
sion and alignment of different interests and needs, followed 
by identification of potential technological solutions that ful-
filled these. 
You can think of it as putting all the interests in one pot 
and then saying what are the solutions that can poten-
tially optimise a successful achievement of the collection 
of all interests together and then can the different stake-
holders live with that. (Participant 5, Policy)
Commercial, academic and provider relationships were 
seen as particularly important, and were often promoted 
by individuals who could span boundaries across these 
sectors. Here, participants gave examples of technologists 
with clinical backgrounds (helping to design technolo-
gies that were needs-based) or academics who worked in 
commercial settings (helping to stay abreast of innovative 
developments). 
We cannot have like old time professors that never 
work in a company or they do some partial work there 
because…they are super out of the world… in the States 
it’s a bit different [to Europe] because most of the profes-
sors work in the real world. (Participant 7, Technologist/
Engineer)
Different examples from the US to promote collaboration 
included partnering small businesses with universities, co-
innovation through collaboration between commercial com-
petitors, giving seed money to small businesses, regional 
venture programs, and pooling of resources. Technology 
hubs and incubator communities were viewed as partic-
ularly important in this context as they allowed individu-
als from different backgrounds to get together deliberate 
issues of common interest and exchange ideas. 
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… to get the right people in the same room to be able to 
look at the same problem and each group brings their 
own perspective. And the same kind of thinking that 
makes a problem isn’t the same kind of thinking that 
will solve the problem…there’s a reason why there are 
hubs of things, there are technology hubs meaning that 
people with a similar slant on things congregate and 
share ideas. (Participant 3, Academic)
Provider attitudes: risk taking and willingness to 
experiment
Many participants argued that an organisational willingness 
to embrace and stimulate change, to experiment and pro-
vide a risk taking environment was key to innovation, but 
healthcare organisations – particularly in the UK where 
funding was tight and immediate care-related activities took 
priority – were seen to be relatively risk-averse. As a result, 
there was a lack of local investment in innovation-related 
activities.
The environment must be willing to take risks and willing 
to allow the sharing of thoughts, communication, data 
and the willingness to mess up sometimes and the will-
ingness to identify good ideas and push them forward. 
(Participant 3, Academic)
This was seen to be exacerbated by a lack of innovative 
mind-sets amongst clinicians, a lack of designated time away 
from providing patient care to engage in such activity, limited 
managerial efforts to promote creative thinking, and a lack 
of collaborative working between informatics staff (which are 
scarce in the UK) and clinical users. Experiences from organ-
isations that were perceived as innovative included providing 
a ‘safe space’ for innovators, who were given the licence to 
engage in blue-sky thinking.
The most innovative organisations bring together the 
most bold thinkers and give them licence to be cre-
ative…the licence to think in unusual and unique ways 
and giving them an incubator to go off and build it [the 
technology]…giving them that empowerment you have 
to change the culture in supporting that environment of 
innovative thinking. (Participant 9, Policy/Technologist)
Ensuring that needs of patients and 
healthcare professionals are addressed
Development of technology should be needs-driven
Despite the range of environmental and organisational fac-
tors that played a role in promoting and/or inhibiting innova-
tion climate, interviewees also cautioned that innovations had 
to be needs-based to be successfully adopted. Increasingly 
high levels of development activity associated with new 
technologies, their surrounding hype and the promise of ‘big 
money’ for some stakeholders were in some respect seen to 
jeopardise this. In addition, the focus on promoting innovative 
activity was seen to create a host of technological solutions 
within the healthcare field that did not necessarily emerge 
from existing health system needs. In other instances, tech-
nological solutions were seen to be introduced to problems 
that did not necessarily require technological intervention. 
…everybody is now looking for the next crazy app that 
will disrupt anything and makes them rich or something. 
But it’s not so much about the technology, it’s more 
about…finding the right solution that really serves the 
whole system... (Participant 4, Clinical Informatics)
Work practices of healthcare professionals, 
human interaction and patient needs
Existing needs included those of local healthcare organisa-
tions, who were perceived to select which innovations to 
pursue based on the characteristics of their local popula-
tions and current national targets, and also the needs of 
clinicians within those organisations. Here, the disrup-
tive nature of some technological systems to clinical work 
practices was mentioned by many, as was the potentially 
adverse impact of new technologies on the personal aspect 
of delivering care. 
…you have to tell me why this is going to help me to take 
care of my patient better, faster and more consistently. If 
you can’t do that, then the technology means absolutely 
nothing…(Participant 9, Policy/Technologist)
Maturity of solutions and associated policies
Participants further referred to potentially adverse conse-
quences for the safety and quality of care that could result from 
the adoption of immature technologies. There was a perceived 
risk amongst some that strategic directions may, in attempting 
to promote innovation nationally and locally, deploy technolo-
gies prematurely and/or implement them without understand-
ing local practices and needs. Thorough evaluation of new 
technologies before they were deployed in healthcare envi-
ronments was therefore viewed as crucial for their safe and 
effective use and in ensuring that innovative technologies were 
empowering, as opposed to undermining policies.
It’s important to support innovation, but also to require 
maturity of the solutions before they’re broadly 
adopted…especially the more political the decision 
making becomes, the more government policies tend to 
adopt the next bright shiny object. (Participant 5, Policy)
DISCUSSION
This study indicates that healthcare innovation should be a 
strategic imperative at national level, ensuring that techno-
logical developments address an established clinical need 
rather than presenting a reactionary response to market 
trends. Both public and private sector input and meaningful 
incentives need to be in place, while recognising the need for 
both competition and collaboration.
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Our analysis has provided insights into how national, 
organisational, and individual factors can contribute to 
creating a climate for technological innovation in health-
care settings. Existing empirical work has, to date, mainly 
focused on exploring organisational climates, somewhat 
neglecting the wider network of stakeholders that need to be 
involved at organisational and national levels. Previously, a 
risk-taking climate and appropriate allocation of resources 
have been identified as organisational factors associated 
with innovativeness.29 Our work builds on these findings, 
by painting a more nuanced picture of the wider innova-
tion landscape, where cross-organisational public/private 
collaboration needs to be combined with national direction 
to coordinate efforts and stimulate competition without sti-
fling innovation. Regulation can in this context play both an 
inhibiting role (as mentioned by our sample) and a facili-
tating one.30 The central direction should involve attracting 
a range of commercial suppliers and preventing the emer-
gence of a monopoly. The limited number of commercial 
vendors has become a real threat to a vibrant commercial 
market in UK HIT since the end of the National Programme 
for Information Technology in England.31 
Interviewees have provided important insights surround-
ing potential ways to stimulate an innovation climate in the 
UK. However, findings relate to a relatively limited num-
ber of participants mainly from US-based settings and with 
expertise in a limited range of technological applications. 
It maybe that saturation was reached partly because of 
the general level of the discussion and limited contexts. 
It is also important to keep in mind that participants were 
positioned within a certain sociopolitical context that may 
have influenced their responses and may limit generalis-
ability of findings to the UK. For example, there was an 
uncritical acceptance by many that technological innova-
tion was inherently ‘good’ reflecting wider socioeconomic 
discourses surrounding the US’ position as an international 
economic leader. Similarly, there are some cultural differ-
ences surrounding professional identity that may have 
impacted on how participants from different sociopolitical 
backgrounds viewed innovation. Many had an interest in 
innovation to flourish as this was a crucial aspect of their 
occupation. We further lacked input from a patient per-
spective, which could have added another dimension sur-
rounding ‘user/patient-pull’ towards stimulating innovative 
activity in particular areas of need. We now plan to explore 
these initial findings in more depth through detailed case 
studies of the most promising technologies identified by 
participants. These included: 1) patient-/person-generated 
data and its integration into electronic health records, 2) 
innovative information infrastructures (e.g. smart facilities 
and cloud-computing), 3) robotics, and 4) novel analytical 
strategies to make better use of existing data. 
Ongoing efforts should emerge from and align with 
local needs of technology users. The NHS has almost 1.7 
million frontline and backend staff – making it the fifth big-
gest employer in the world – who could help to identify 
these needs and opportunities, but no large scale efforts 
to do so have to date been made.32,33 This is therefore 
an essential next step that needs to be taken through for 
example creating national innovation centres that promote 
conception, development and testing of innovations, and 
by working in partnership with frontline healthcare staff 
and patients.34,35
Existing conceptual models of the policy process have 
recognised this need to begin with a definition of a prob-
lem and then strategically plan policies based on this, but 
these processes are rarely followed in the real world.36–38 
Especially in healthcare polices, this needs-based model is 
not always followed, perhaps because organisational and 
user needs vary so significantly, and the political context 
where there is still substantial debate about the optimal 
degree of involvement of national governments in health-
care policy.39 
Effective public/private alliances were found to result in 
access to a range of resources/insights that were otherwise 
untapped, with healthcare organisations offering insights into 
opportunities for technological innovation based on organ-
isational/individual need, and industry providing access to 
technological solutions (what Dyer and Singh call ‘com-
plementary capabilities’).40 Hence, the widely advocated 
focus on creating innovation centres seems appropriate, 
although some barriers to their success have been identi-
fied including shortage of funding, lack of integration with 
clinical settings, and sub-optimal sharing mechanisms.19,41 
Our analysis suggested that for these actors to contribute 
to a wider innovation climate, competition is necessary to 
stimulate activity. 
Although a number of initiatives in the UK exist to promote 
healthcare innovation (see Box 4),42–47 there is still a lot of room 
for improvement. Achieving a balance between central coordi-
nation of innovative activity to spread knowledge and stimulate 
competition, and local collaboration to identify needs and build 
solutions based on these, should be a defining characteristic 
of national health policy. Such efforts should be characterised 
by creating safe spaces for collaborative endeavours, devising 
incentives to promote innovative activity, creating innovative 
funding models, and building a climate where experimentation 
and potential associated ‘failure’ is encouraged rather than 
shied away from. There may also be scope to follow a flex-
ible approach to healthcare innovation policy that leverages 
relationships with academia, non-profit organisations and pri-
vate sector organisations to help develop a roadmap for inno-
vation strategies in the UK. This should be revisited regularly 
for public comment. Such an approach is already successfully 
employed in the US,48 and could help to ensure that public 
policy and government regulations and associated adoption of 
new healthcare innovation efforts is sustainable for the health-
care delivery community at large. 
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 5. Taiwan and South Korea named as Asia’s innovation leaders. 
Available from: http://www.cosmeticsdesign-asia.com/Market-
Trends/Taiwan-and-South-Korea-named-as-Asia-s-innovation-
leaders. Accessed 15 May 2016.
 6. These are the world’s most innovative economies. Available 
from: http://www.bloomberg.com/news/articles/2016-01-19/
these-are-the-world-s-most-innovative-economies. Accessed 
15 May 2016.
 7. Lee PC and Su HN. Evolution of science, technology and 
innovation policy in Asia: case of China, South Korea, Japan 
and Taiwan. 2015 Portland International Conference on 
Management of Engineering and Technology (PICMET), IEEE, 
2015, pp. 184–191.
 8. Why Germany Dominates the U.S. in Innovation. Available 
from: https://hbr.org/2014/05/why-germany-dominates-the-u-s-
in-innovation/. Accessed: 15 May 2016.
Box 4 Current national initiatives in the UK to promote 
healthcare innovation
Patent box legislation: reduces tax paid by commercial 
companies on profits made through patents 
Small business research initiative: supports small- and 
medium-sized enterprises (SMEs) in creating and commer-
cialising innovative ideas that address public sector issues, 
including healthcare 
Innovation vouchers programme: vouchers available 
to SMEs designed to pay for expert input e.g. from 
universities 
Launchpads scheme: central funding to run R&D projects 
for SMEs to develop new products or services
British Business Bank: an economic development bank 
with the aim to provide good credit conditions and strategic/
financial advice to SMEs
Catapult centres: centres of excellence that connect aca-
demic and commercial partners and provide funding to pro-
mote innovation 
R&D expenditure credit (RDEC) scheme: providing tax 
credits for SMEs
R&D allowance: tax breaks for money spent on R&D
New legislation on copyright streamlining intellectual prop-
erty applications
Centralised funding for universities encouraging partner-
ships with SMEs
Increasing investment in system evaluations
International Education Council: promotes the relationship 
between higher education and research (with the aim to 
retain talent)
UK Trade and Investment: promoting links between SMEs 
and global funding opportunities
Silver Public Procurement to promote public–private 
partnerships
CONCLUSIONS
We have identified factors associated with creating a climate 
for healthcare innovation by consulting a range of innovators 
from high performing international health systems. In attempt-
ing to identify potentially transferable lessons for UK health-
care, we found that health system level factors are important 
in stimulating innovation through creating incentives and 
promoting competition, whilst public/private partnerships can 
help to find novel solutions to existing problems. Individual 
users of technologies play an important part throughout this 
process, as developed systems and associated policies 
should address an established need, ensuring that new tech-
nologies provide solutions to challenges faced by health sys-
tems and do not become a new threat. Providers should now 
be consulted to identify ‘pain points’ that healthcare innova-
tion can and needs to address. 
Overall, it is important to keep in mind that even the most 
innovative organisations at times doubt strategic directions and 
revert back to old habits. However, they seem to have an inher-
ent drive to move forward. This drive should be harnessed, 
championed by healthcare pioneers that learn and share les-
sons globally to address healthcare’s increasing challenges.
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